VRP - Invesco Variable Rate Preferred ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
-0.02 (-0.08%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close25.65
Bid25.65 x 1000
Ask25.66 x 3000
Day's Range25.62 - 25.79
52 Week Range24.27 - 26.46
Avg. Volume256,200
Net Assets1.75B
PE Ratio (TTM)N/A
YTD Daily Total Return1.14%
Beta (5Y Monthly)0.23
Expense Ratio (net)0.50%
Inception Date2014-05-01
  • MarketWatch

    Verona Pharma shares shoot higher on Phase 2 trial of respiratory drug

    Verona Pharma surged 69% in London trade as the biopharma said a Phase 2b study evaluating a drug for chronic obstructive pulmonary disease met its primary endpoint of improved lung function. The study of nebulized ensifentrine as an add-on treatment to tiotropium found a statistically significant and clinically meaningful improvement in lung function at week 4.